Strawberry Fields REIT (STRW) Q2 2026 Earnings Call Transcript

Strawberry Fields REIT reported 1H 2026 total revenue of $80.0M (+6.4%) and net income of $18.4M, with AFFO of $73.9M (11% CAGR) and 2026 projected AFFO per share growth of 10.1%. The company maintained 100% contractual rent collection, improved occupancy to 77%, and announced a $0.17/share Q3 2026 dividend (4.9% annualized yield) with a 50.6% AFFO payout ratio. Liquidity was strengthened via a $300M corporate credit facility (SOFR + 2.75%) and the company highlighted a $225M active deal pipeline despite calling 2026 a “slow growth” year due to wonky deal timing/tenancy transitions.

Analysis

The real story is not the quarter; it is whether the company can convert a long-duration refinancing event into a lower cost of capital before the acquisition window re-opens. If that works, equity holders are buying a levered spread business: mid-teen asset yields funded with sub-7% debt and a roughly 50% payout ratio. The near-term market risk is that late-closing assets do not move per-share cash flow quickly enough, so the stock may not get immediate credit for "pipeline" until the acquisitions are actually on balance sheet.

The main beneficiaries are small private SNF owners and regional operators that need liquidity and can tolerate a master-lease structure; this is basically a consolidator tax on fragmented supply. The losers are higher-cost peers that need more equity issuance to grow, because every deal that clears at a disciplined cap rate reinforces the idea that public capital can still underwrite niche healthcare real estate better than private buyers. Second-order, a successful roll-up could compress acquisition yields across the SNF REIT cohort if more sellers come to market, but that is only positive if the firm’s own financing stays cheap.

The hidden risk is that this is still a credit story disguised as an equity story. A change in operator coverage, Medicaid pressure, or any stumble in the debt refi would hit the multiple before it hits rent; the market will not wait for a default to reprice a 91% SNF book. The contrarian view is that the apparent valuation discount may be partially structural, not temporary: the market may be assigning a permanent discount to concentration, small-cap liquidity, and self-marked asset values rather than missing an obvious rerating opportunity.

Key Decisions for Investors

• Do not chase immediately; treat STRW as a post-close confirmation trade and look to add only after the Q3 financing and at least one Q4 acquisition close are publicly visible.
• Tactical long STRW only if the next debt takeout comes in at or below ~7% and management shows that late-year deal flow is converting into AFFO accretion; thesis weakens if funding costs drift back toward 8%.
• Pair trade idea for 1-3 months: long STRW vs short a higher-quality SNF REIT basket (for example SBRA/NHI) if you want to express the view that valuation discount closure will come from growth, not balance-sheet quality.
• Use a hard stop/falsifier on the equity if rent coverage falls materially below 2.0x or rent collection slips off 100%; that would undermine the "bulletproof income stream" argument faster than any cap-rate debate.
• Alert item, not a trade: if the company can prove the Israeli refinancing plus Q4 pipeline translates into a visible step-up in 2027 AFFO, the stock can work over 6-18 months even if the next few weeks are choppy.